The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute (TGen) Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study
4/2/2012 10:04:07 AM
NORWALK, Conn. & PHOENIX--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced a unique oncology research partnership. This multi-year agreement involves several partners including the Translational Genomics Research Institute (TGen), Spectrum Health, and the Van Andel Research Institute (VARI). The collaboration will provide a broad range of genomic services and analyses to help drive the success of the landmark 1000-patient study on the molecular segments and variation of multiple myeloma which has been launched by the MMRF.